Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
Yanmeng Feng, Yifan Zhang, Zhangyufan He, et al.
EClinicalMedicine (2021) Vol. 43, pp. 101226-101226
Open Access | Times Cited: 62
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 24
RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine
Tamás Ferenci, Balázs Sarkadi
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 25
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 79-103
Open Access | Times Cited: 19
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
COVID-19 Vaccine Effectiveness in Preventing SARS-CoV-2 Infection and Antibody Response Among Health Care Workers in Base Hospital Wathupitiwala, Sri Lanka
WAMP Samaranayake
(2025), pp. 1-8
Closed Access
Evaluation of the gene expression of CD27 and CD73, and the anti-SARS-CoV-2 Spike IgG level before and after receiving the inactivated SARS-COV-2 vaccine
Ali Mostafaei, Mojtaba Jafarinia, Mohammad Kargar, et al.
Gene Reports (2025), pp. 102196-102196
Closed Access
COVID-19 vaccines: Update of the vaccines in use and under development
Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, et al.
Vacunas (2022) Vol. 23, pp. S88-S102
Open Access | Times Cited: 15
IgG Antibody Responses and Immune Persistence of Two Doses of BBIBP-CorV Vaccine or CoronaVac Vaccine in People Living with HIV (PLWH) in Shenzhen, China
Guang Zeng, Liumei Xu, Shuidong Feng, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 880-880
Open Access | Times Cited: 14
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
Chandima Jeewandara, Suranga Fernando, Pradeep Darshana Pushpakumara, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines
Fawzi Ebrahim, Salah Tabal, Yosra Lamami, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2002-2002
Open Access | Times Cited: 12
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Laksiri Gomes, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 11
Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population
Javeria Aijaz, Shakir Hussain, Fouzia Naseer, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 692-692
Open Access | Times Cited: 10
Anti-SARS-CoV-2 Antibody Responses 5 Months Post Complete Vaccination of Moroccan Healthcare Workers
Najlaa Assaid, Soukaina Arich, Hicham Charoute, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 465-465
Open Access | Times Cited: 9
Mix-and-match COVID-19 vaccines trigger high antibody response after the third dose vaccine in Moroccan health care workers
Houda Amellal, Najlaa Assaid, Khadija Akarid, et al.
Vaccine X (2023) Vol. 14, pp. 100288-100288
Open Access | Times Cited: 5
Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers
Hamed Zare, Hadis Rezapour, Alireza Fereidouni, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Chandima Jeewandara, Inoka Sepali Aberathna, Laksiri Gomes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Omicron reactive multi protein specific CD4 T cells defines cellular immune response induced by inactivated virus vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
Chandima Jeewandara, K. A. Chintha S. Jayampathi, Thushali Ranasinghe, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 7, pp. e0000607-e0000607
Open Access | Times Cited: 4
Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
Verónica Galván, Jorge Quarleri
GeroScience (2021) Vol. 44, Iss. 1, pp. 57-61
Open Access | Times Cited: 5
Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka
Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Advances in the Adverse Effects of Covid-19 Vaccination and the Concept of Vaccine Development
Md Sadique Hussain, Sandeep Singh, Garima Dhingra, et al.
Journal of Pharmaceutical Research International (2022), pp. 19-38
Open Access | Times Cited: 3
Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco)
Taoufik Ben Houmich, Abdelali Tali, Fayrouz Debbagh, et al.
International Journal of Immunopathology and Pharmacology (2022) Vol. 36, pp. 039463202211336-039463202211336
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top